BCM
GILD icon

BTR Capital Management’s Gilead Sciences GILD Stock Holding History

BTR Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,951
Closed -$594K – 156
2020
Q1 		$594K Sell
7,951
-16,506
-67% -$1.14M 0.13% 88
2019
Q4 		$1.59M Sell
24,457
-3,757
-13% -$245K 0.27% 65
2019
Q3 		$1.79M Buy
28,214
+20
+0.1% +$1.31K 0.34% 60
2019
Q2 		$1.91M Sell
28,194
-200
-0.7% -$13.2K 0.36% 57
2019
Q1 		$1.85M Sell
28,394
-1,405
-5% -$93.4K 0.35% 57
2018
Q4 		$1.86M Sell
29,799
-5,965
-17% -$417K 0.39% 54
2018
Q3 		$2.76M Buy
35,764
+363
+1% +$27.4K 0.48% 46
2018
Q2 		$2.51M Sell
35,401
-137
-0.4% -$9.67K 0.48% 45
2018
Q1 		$2.68M Sell
35,538
-1,008
-3% -$80.1K 0.54% 42
2017
Q4 		$2.62M Sell
36,546
-9,137
-20% -$694K 0.51% 43
2017
Q3 		$3.7M Sell
45,683
-7,467
-14% -$571K 0.75% 42
2017
Q2 		$3.76M Sell
53,150
-5,700
-10% -$379K 0.77% 42
2017
Q1 		$4M Sell
58,850
-51,337
-47% -$3.61M 0.84% 41
2016
Q4 		$8.72M Hold
110,187
– – 1.96% 17
2016
Q3 		$8.72M Buy
110,187
+25,150
+30% +$2.04M 1.96% 17
2016
Q2 		$7.09M Buy
85,037
+2,235
+3% +$198K 1.63% 24
2016
Q1 		$7.61M Buy
82,802
+4,165
+5% +$376K 1.77% 20
2015
Q4 		$7.96M Buy
78,637
+4,675
+6% +$486K 1.81% 20
2015
Q3 		$7.26M Buy
73,962
+28,737
+64% +$3.19M 1.74% 20
2015
Q2 		$5.29M Buy
45,225
+1,930
+4% +$211K 1.25% 31
2015
Q1 		$4.25M Buy
43,295
+16,265
+60% +$1.65M 1.03% 39
2014
Q4 		$2.55M Sell
27,030
-1,570
-5% -$162K 0.69% 50
2014
Q3 		$3.04M Sell
28,600
-230
-0.8% -$22.5K 0.84% 43
2014
Q2 		$2.39M Buy
28,830
+2,187
+8% +$170K 0.66% 49
2014
Q1 		$1.89M Sell
26,643
-1,612
-6% -$126K 0.55% 53
2013
Q4 		$2.12M Sell
28,255
-3,425
-11% -$238K 0.61% 50
2013
Q3 		$1.99M Sell
31,680
-1,970
-6% -$118K 0.63% 48
2013
Q2 		$1.73M Buy
+33,650
New +$1.75M 0.54% 52

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

BTR Capital Management's GILD Position: Q2 2020 in Review

BTR Capital Management sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 7,951 shares — an estimated $594K sold.

BTR Capital Management first reported a position in GILD in Q2 2013 and held it in 28 quarters. The position peaked at $8.72M in Q4 2016. 1,625 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • BTR Capital Management reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
  • BTR Capital Management sold 7,951 Gilead Sciences shares in Q2 2020, an estimated $594K.
  • BTR Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 28 quarters.
  • BTR Capital Management's Gilead Sciences position peaked at $8.72M in Q4 2016.
  • 1,625 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on BTR Capital Management's 13F filing for Q2 2020, filed 23 Jul 2020.